» Articles » PMID: 522894

Propranolol in Conscious Spontaneously Hypertensive Rats. II. Disposition After Subcutaneous and Intracerebroventricular Administration

Overview
Specialty Pharmacology
Date 1979 Oct 1
PMID 522894
Citations 9
Authors
Affiliations
Soon will be listed here.
Abstract

The disposition of dl-propranolol was studied in spontaneously hypertensive rats (SHR), both after subcutaneous (s.c.) and intracerebroventricular (i.c.v.) injection of 1 mg/kg. 1. Upon s.c. injection propranolol appeared rapidly in plasma. A maximum concentration of 374 +/- 33 ng/ml (N = 10) was reached 5 min after injection. After a distribution phase with a half-life of t 1/2 alpha = 17 min propranolol was eliminated with a t 1/2 beta = 59 min. 2. Both propranolol and its metabolites were taken up rapidly into all tissues studied. Highest concentrations (10.4 +/- 1.5 micrograms/g, N = 5) were found in lungs 30 min after injection. 3. Neither propranolol nor its metabolites accumulated in any of the tissues examined. 4. Upon i.c.v. injection of propranolol, a maximal concentration of 573 +/- 47 ng/ml (N = 3) was reached in plasma already 2 min after injection. In this case t 1/2 alpha was 13 min and t 1/2 beta was 80 min. 5. Dialysis experiments indicated that propranolol is bound to plasma proteins for 92% in the concentration range of 20--100 ng/ml. With increasing concentrations binding diminishes progressively. At the highest concentration tested (345 ng/ml) only 76% was bound. It is concluded that s.c. and i.c.v. injection of an identical dose of propranolol gives a similar plasma concentration-time profile. Moreover, it is suggested that the pharmacokinetic behaviour of propranolol in SHR does not explain the delayed antihypertensive effect of this drug.

Citing Articles

Ocular Versus Oral Propranolol for Prevention and/or Treatment of Oxygen-Induced Retinopathy in a Rat Model.

Qadri A, Cai C, Deslouches K, Siddiqui F, Aranda J, Beharry K J Ocul Pharmacol Ther. 2021; 37(2):112-130.

PMID: 33535016 PMC: 7984658. DOI: 10.1089/jop.2020.0092.


β-adrenergic modulation of discrimination learning and memory in the auditory cortex.

Schicknick H, Henschke J, Budinger E, Ohl F, Gundelfinger E, Tischmeyer W Eur J Neurosci. 2019; 50(7):3141-3163.

PMID: 31162753 PMC: 6900137. DOI: 10.1111/ejn.14480.


Methionine Restriction Partly Recapitulates the Sympathetically Mediated Enhanced Energy Expenditure Induced by Total Amino Acid Restriction in Rats.

Spring S, Singh A, Zapata R, Chelikani P, Pezeshki A Nutrients. 2019; 11(3).

PMID: 30917593 PMC: 6470753. DOI: 10.3390/nu11030707.


Locus Coeruleus Stimulation Facilitates Long-Term Depression in the Dentate Gyrus That Requires Activation of β-Adrenergic Receptors.

Hansen N, Manahan-Vaughan D Cereb Cortex. 2014; 25(7):1889-96.

PMID: 24464942 PMC: 4459289. DOI: 10.1093/cercor/bht429.


Avoidance of "first-pass" elimination of rectally administered propranolol in relation to the site of absorption in rats.

de Leede L, De Boer A, Havermans J, Breimer D Pharm Res. 2013; 1(4):164-8.

PMID: 24277285 DOI: 10.1023/A:1016396508058.


References
1.
Smits J, van Essen H . The role of the baroreceptor reflex in the cardiovascular effects of propranolol in the conscious spontaneously hypertensive rat. Clin Sci (Lond). 1979; 56(2):163-7. DOI: 10.1042/cs0560163. View

2.
Smits J, van Essen H . Propranolol in conscious spontaneously hypertensive rats. I. Cardiovascular effects after subcutaneous and intracerebroventricular administration. Naunyn Schmiedebergs Arch Pharmacol. 1979; 309(1):13-8. DOI: 10.1007/BF00498751. View

3.
Hansson L, Zweifler A, Julius S, Hunyor S . Hemodynamic effects of acute and prolonged beta-adrenergic blockade in essential hypertension. Acta Med Scand. 1974; 196(1-2):27-34. DOI: 10.1111/j.0954-6820.1974.tb00962.x. View

4.
Migdalof B . Methods for obtaining drug time course data from individual small laboratory animals: serial microblood sampling and assay. Drug Metab Rev. 1976; 5(2):295-310. DOI: 10.3109/03602537609029981. View

5.
Smits J . The osmotic minipump: a new tool in the study of steady-state kinetics of drug distribution and metabolism. J Pharm Pharmacol. 1978; 30(9):576-8. DOI: 10.1111/j.2042-7158.1978.tb13327.x. View